Analysis of the methylation level of the GAS5 promoter using TCGA data in the UALCAN database showed statistically significant differences (p < 0.0001) between normal and primary tumor samples in CHOL (Figure 10A), KIRC (Figure 10B), and LIHC (Figure 10C). The gene discussed is GAS5; the disease is neoplasm.